Table 2

 Clinical characteristics of the patients by treatment group

Folic acid (n = 15)Placebo (n = 16)
Values are number (%) of patients.
No of adenomas
    111 (73%)11 (69%)
    1–33 (20%)5 (31%)
    >31 (7%)0 (0%)
Type of adenoma
    Tubular2 (13%)1 (6%)
    Tubulovillous11 (73%)12 (75%)
    Villous2 (13%)2 (13%)
    Serrated0 (0%)1 (6%)
Degree of dysplasia
    Mild3 (20%)2 (13%)
    Moderate9 (60%)9 (56%)
    Severe3 (20%)4 (25%)